Replies to post #671283 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

You are arguing out of both sides of your mouth. In the post I’m responding to you totally ignore:

1. That the Eden system is specifically designed for DCVax specifications.
2. That the Eden system will be proven to reach those end product specifications, imo.
3. That the Eden system is patented, and will be further patented to outline the optimization.
4. That NWBO owns Flaskworks.
5. That the end product is DCVax-l.
6. That the end product is protected by biologic exclusive use for ten years from time of approval.
7. That there is data exclusivity for the phase iii trial (safety and efficacy) for five years.
8. That other autologous whole lysate pulsed dendritic therapies are at best several years from obtaining approval.